Aequs promoter warrants could bring roughly ₹650 crore into the Karnataka-based precision manufacturer after its board approved a preferential issue on September 25. Half the amount—₹325 crore—is payable when the warrants are allotted, while the rest arrives only if the promoter-group subscriber exercises them.
The Aequs promoter warrants are staged financing, not an instant ₹650 crore equity injection. The structure gives the company ₹325 crore at allotment and leaves the second half conditional on conversion, so investors should separate authorised proceeds from cash actually received.
Everyone else is reporting the issue size; we are explaining how the two-step payment changes timing, dilution and execution risk.
How the Aequs promoter warrants work
Aequs’ official investor record and same-event reports from CNBC-TV18 and Business Upturn agree on the core terms. The board approved warrants convertible one-for-one into equity shares, issued to a promoter-group trustee for ₹231.55 each. The total, if every warrant is allotted and exercised, is ₹6,499,999,819.50.
| Item | Detail |
|---|---|
| Warrants | Up to 28,071,690 |
| Price | ₹231.55 each |
| Maximum proceeds | About ₹650 crore |
| Paid at allotment | ₹325 crore |
| EGM | October 22, 2026 |
Why the payment split matters
The 50% upfront contribution is twice the common 25% minimum described in the company announcement. That raises the promoter’s immediate cash commitment and gives Aequs a larger first tranche, but it does not remove execution risk or guarantee that the remaining warrants will convert.
Aequs said the funds support expansion, yet the board outcome does not by itself prove a return on capital. Readers should watch the final shareholder resolution, allotment, conversion disclosures and project-specific deployment. Capacity commissioned, customer orders and utilisation will matter more than the headline authorisation.
The structure resembles the capital-timing question in Zelio’s preferential growth issue. It also sits inside the broader manufacturing-depth challenge covered in India’s PLI manufacturing review: fresh money creates value only when it turns into productive assets and durable orders.
What shareholders should track
The October 22 vote is the first checkpoint. After that, investors need the allotment date, revised share count, promoter holding and actual use of funds. Because the warrants are convertible securities, dilution occurs with conversion rather than merely with board approval.
The bottom line: the Aequs promoter warrants create a credible ₹650 crore funding path with unusually strong upfront funding. They do not yet establish that the entire amount has arrived—or that expansion will earn an adequate return.
FAQs
What did Aequs approve?
Aequs approved up to 28,071,690 warrants at ₹231.55 each for a promoter-group trustee.
How much is payable upfront?
₹325 crore, equal to half the maximum issue value, is payable at allotment.
When do shareholders vote?
The company scheduled an extraordinary general meeting for October 22, 2026.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
